Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Mary Anne Rossing
Affiliation
Fred Hutchinson Cancer Research Center
ORCID
Career Start Year
1989
Papers
175
H Index
50
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
34789471
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.
Cancer Epidemiol Biomarkers Prev
2022
32546565
Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.
J Med Genet
2021
33990587
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Nat Commun
2021
32766851
Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies.
J Natl Cancer Inst
2021
32239218
Association Between Breastfeeding and Ovarian Cancer Risk.
JAMA Oncol
2020
32028322
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship Explored.
Epidemiology
2020
32641237
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.
Gynecol Oncol
2020
32554541
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Clin Cancer Res
2020
32473302
Prognostic gene expression signature for high-grade serous ovarian cancer.
Ann Oncol
2020
29718305
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
J Natl Cancer Inst
2019
31211375
Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.
Int J Epidemiol
2019
31548585
Publisher Correction: Shared heritability and functional enrichment across six solid cancers.
Nat Commun
2019
31001917
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.
Cancer Med
2019
30499236
A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants.
Int J Cancer
2019
30683880
Shared heritability and functional enrichment across six solid cancers.
Nat Commun
2019
28633381
Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence.
Am J Epidemiol
2018
30134598
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.
Int J Mol Sci
2018
30054336
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.
Cancer Res
2018
30121132
Histotype classification of ovarian carcinoma: A comparison of approaches.
Gynecol Oncol
2018
30062862
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.
J Pathol Clin Res
2018
29979793
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.
PLoS One
2018
29555990
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
Br J Cancer
2018
29584862
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.
Int J Epidemiol
2018
29247577
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium.
Cancer Sci
2018
29141849
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.
Cancer Epidemiol Biomarkers Prev
2018
29211900
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.
Int J Epidemiol
2018
28833087
Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium.
Int J Cancer
2018
28063166
Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.
Int J Cancer
2017
28103614
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.
Br J Cancer
2017
28350790
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.
Br J Cancer
2017
28293802
History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.
Cancer Causes Control
2017
28346442
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nat Genet
2017
28699174
Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
Int J Cancer
2017
28864456
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.
Cancer Epidemiol Biomarkers Prev
2017
28817835
History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.
Br J Cancer
2017
27677730
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.
Cancer Epidemiol Biomarkers Prev
2017
28035019
Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.
Cancer Epidemiol Biomarkers Prev
2017
27941069
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.
Am J Epidemiol
2017
25940428
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecol Oncol
2016
27698005
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.
Am J Epidemiol
2016
27601076
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Nat Commun
2016
27595995
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
J Med Genet
2016
27911851
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.
Oncotarget
2016
27594614
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.
Int J Epidemiol
2016
27533245
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
Oncotarget
2016
27299959
Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.
Br J Cancer
2016
27420401
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.
Int J Cancer
2016
27197285
Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.
Cancer Epidemiol Biomarkers Prev
2016
27378695
Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.
Hum Mol Genet
2016
27401727
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.
Int J Epidemiol
2016
1 - 50 of 175
Column Actions
Search
Recommended Authors
Mollie E Barnard
Boston University Chobanian & Avedisian School of Medicine
Career Start Year
2011
Number of shared co-authors
19
Hui-Chun Irene Su
University of California San Diego
Career Start Year
2008
Number of shared co-authors
1
Jeanine M Genkinger
Mailman School of Public Health, Columbia University
Career Start Year
2001
Number of shared co-authors
16
Clarisa R Gracia
Hospital of the University of Pennsylvania
Career Start Year
1999
Number of shared co-authors
1
Susan C Modesitt
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year
1998
Number of shared co-authors
5
Reina Haque
Southern California Permanente Medical Group
Career Start Year
1998
Number of shared co-authors
2
Dina N Paltoo
National Institutes of Health
Career Start Year
1998
Number of shared co-authors
6
Wanqing Wen
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year
1998
Number of shared co-authors
60
James V Lacey
Beckman Research Institute of City of Hope
Career Start Year
1997
Number of shared co-authors
71
Mary D Sammel
University of Colorado Anschutz Medical Campus
Career Start Year
1996
Number of shared co-authors
2
Sheila Weinmann
Center for Health Research, Kaiser Permanente Northwest Research Center
Career Start Year
1994
Number of shared co-authors
7
Carmen Rodriguez
Institut de Recherche en Cancerologie de Montpellier
Career Start Year
1993
Number of shared co-authors
17
Gordon Fehringer
Inc. San Carlos
Career Start Year
1993
Number of shared co-authors
41
George L Maxwell
Women's Health Integrated Research Center, Inova Health System
Career Start Year
1992
Number of shared co-authors
66
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year
1991
Number of shared co-authors
12
Edward L Giovannucci
Harvard T.H. Chan School of Public Health
Career Start Year
1990
Number of shared co-authors
83
Ruth M Pfeiffer
National Cancer Institute.
Career Start Year
1990
Number of shared co-authors
39
Jeffery P Struewing
National Human Genome Research Institute, National Institutes of Health
Career Start Year
1988
Number of shared co-authors
44
Fran??ois Meyer
Laval University
Career Start Year
1986
Number of shared co-authors
2
Stephen K Van Den Eeden
Kaiser Permanente Northern California, University of California san francisco
Career Start Year
1985
Number of shared co-authors
58
David Tritchler
University at Buffalo
Career Start Year
1984
Number of shared co-authors
6
John A Baron
University of North Carolina at Chapel Hill
Career Start Year
1983
Number of shared co-authors
35
Dennis Deapen
Keck School of Medicine, University of Southern California
Career Start Year
1981
Number of shared co-authors
13
Daniela Seminara
National Cancer Institute, 9609 Medical Center Dr
Career Start Year
1981
Number of shared co-authors
82
Thomas E Rohan
Albert Einstein College of Medicine
Career Start Year
1980
Number of shared co-authors
51
Graham A Colditz
Washington University School of Medicine
Career Start Year
1978
Number of shared co-authors
58
Sholom Wacholder
National Cancer Institute
Career Start Year
1977
Number of shared co-authors
40
Kenneth C Chu
Ontario Institute for Cancer Research
Career Start Year
1974
Number of shared co-authors
6
Robert A Hiatt
University of California San Francisco
Career Start Year
1968
Number of shared co-authors
18
Joseph F Fraumeni
National Cancer Institute
Career Start Year
1959
Number of shared co-authors
67
row(s) 1 - 30 of 30
Collaborators
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers
112
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers
96
Anna H Wu
University of Southern California
Co-authored papers
94
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers
93
Andrew Berchuck
Duke School of Medicine
Co-authored papers
93
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers
92
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers
79
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers
78
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers
77
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers
77
Hoda Anton-Culver
University of California irvine
Co-authored papers
76
Usha Menon
College of Nursing, University of South Florida
Co-authored papers
74
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers
73
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers
71
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers
71
Elisa V Bandera
Co-authored papers
70
Alice S Whittemore
Co-authored papers
62
Honglin Song
University of Cambridge
Co-authored papers
62
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers
60
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers
60
Weiva Sieh
Co-authored papers
59
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers
56
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers
52
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers
50
Pamela J Thompson
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers
50
Lambertus A Kiemeney
Co-authored papers
48
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers
48
Douglas A Levine
Perlmutter Cancer Center
Co-authored papers
47
Jan Lubinski
Pomeranian Medical University
Co-authored papers
47
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers
46
1 - 30